Outcome of Living Donor Liver Transplantation for Egyptian Patients With Hepatitis C (Genotype 4)-Related Cirrhosis

Transplantation Proceedings

Volumn 40, Issue 5, 2008, Pages 1481-1484

  Yosry, A ^a   Esmat, G ^a   El Serafy, M ^a   Omar, A ^a   Doss, W ^a   Said, M ^a   Abdel Bary, A ^a   Hosny, A ^a   Marawan, I ^a   El Malt, O ^a   Kamel, R R ^a   Hatata, Y ^a   Ghali, A ^a   Sabri, H ^a   Kamel, S ^a   El Gbaly, H ^a   Tanaka, K ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; STEROID; TACROLIMUS;

ADULT; AGE; ARTICLE; EGYPT; FEMALE; FOLLOW UP; GENDER; GENOTYPE; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FIBROSIS; LIVER GRAFT REJECTION; LIVER REGENERATION; LIVER TRANSPLANTATION; LIVER WEIGHT; LIVING DONOR; LIVING DONOR LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT VIRUS INFECTION; RISK FACTOR; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; CARCINOMA, HEPATOCELLULAR; EGYPT; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 45449102467     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.03.085     Document Type: Article

References (12)

1. Hepatitis C 2002. Resource Centre Communicable Diseases, World Health Organization. 2002. http://www.who.int/ith/chapter05_m05_hepatitis.html
2. Heintges T., and Wands J.R. Hepatitis C virus: Epidemiology and transmission. Hepatology 26 (1997) 521
3. Strickland G.T., Elhefni H., Salman T., et al. Role of Hepatitis C Infection in Chronic Liver Disease in Egypt. Am J Trop Hyg 67 (2002) 436
4. Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. J Hepatol 22 (1995) 696
5. Takada Y., Haga H., Ito T., et al. Clinical Outcomes of Living Donor Liver Transplantation for Hepatitis C Virus (HCV)-Positive Patients. Transplantation 81 (2006) 350
6. Berenguer M., Prieto M., Juan F.S., et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 36 (2002) 202
7. Berenguer M., Prieto M., Cordoba J., et al. Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection. J Hepatol 28 (1998) 756
8. Berenguer M. What determines the natural history of recurrent hepatitis C after liver transplantation?. J Hepatol 42 (2005) 448
9. Gane E. The natural history and outcome of liver transplantation in hepatitis C virus infected recipients. Liver Transplant 9 (2003) S28
10. Russo M.W., Galanko J., Beavers K., et al. Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States. Liver Transpl 10 (2004) 340
11. Gane E.J., Portmann B.C., Naoumov N.V., et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334 (1996) 815
12. Garcia-Retortillo M., Forns X., Llovet J.M., et al. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Hepatology 40 (2004) 699